Effect of Tocilizumab on Clinical Outcomes at 15 Days in Patients With Severe or Critical COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
BMJ: British Medical Journal
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Tocilizumab on Clinical Outcomes at 15 Days in Patients With Severe or Critical Coronavirus Disease 2019: Randomised Controlled Trial
BMJ 2021 Jan 20;372(xx)n84, VC Veiga, JAGG Prats, DLC Farias, RG Rosa, LK Dourado, FG Zampieri, FR Machado, RD Lopes, O Berwanger, LCP Azevedo, Á Avezum, TC Lisboa, SSO Rojas, JC Coelho, RT Leite, JC Carvalho, LEC Andrade, AF Sandes, MCT Pintão, CG Castro, SV Santos, TML de Almeida, AN Costa, OCE Gebara, FGR de Freitas, ES Pacheco, DJB Machado, J Martin, FG Conceição, SRR Siqueira, LP Damiani, LM Ishihara, D Schneider, D de Souza, AB Cavalcanti, P ScheinbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.